Remedium Bio were accepted into the P4precision medicine accelerator program
Posted:
Remedium Bio were accepted into the P4precision medicine accelerator program, a collaboration of UCL, London’s Global University, and Capital Enterprise, the UK’s largest startup ecosystem!
Generative AI voice agents—conversational systems powered by large language models that can understand and produce natural speech in real time—are poised to transform how health systems engage with patients.
Read more here.
Stanford Medicine researchers developed a way to create the first heart and liver organoids that generate their own blood vessels, possibly paving the way for organoid-based regenerative therapies.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us